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Summary The effect of human peripheral blood monocytes on the SW626 ovarian carcinoma line was
investigated in a colony assay in agar, Percoll-enriched monocytes inhibited colony formation by SW626
carcinoma cells at effector-to-target cell (E:T) ratios as low as 0.3: 1. In contrast the same effectors had little
cytolytic effect in a 48h thymidine-release assay at E: T ratios as high as 40:1. Monocyte-depleted
nonadherent cells had little inhibitory capacity on SW626 colony formation, whereas unseparated
mononuclear cells were intermediate between Percoll-enriched monocytes and lymphoid cells. Sorting of cells
positive for the monoclonal antibody marker M02 confirmed the monocytic nature of cells which inhibited
colony formation. Ovarian carcinoma cells freshly isolated from 9 patients were heterogenous in their
susceptibility to colony inhibition by mononuclear phagocytes. Cells from 4 patients were not inhibited by
effector cells and in one subject promotion of colony formation by mononuclear phagocytes was observed.
With 4 cell preparations inhibition of colony formation was found as with the SW626 line. Colony assays
may provide a useful methodological approach, particularly when effector cells mediate low levels of killing,
of doubtful biological significance, in conventional isotope release assays, or when growth promotion is to be
evaluated.
The interaction of cells of the monocyte-
macrophage series with tumour cells is complex.
Mononuclear phagocytes can kill tumour cells in
vitro by various mechanisms, including neutral
proteases, reactive oxygen intermediates and ill-
defined 'factors' (reviewed by Adams & Snyderman,
1979). On the other hand, cells of the monocyte-
macrophage series are potent producers of growth
factors, that, under certain circumstances, can
promote tumour growth in vitro or in vivo (reviewed
by Evans, 1979; Mantovani, 1983). Under many
conditions, most notably with solid human
tumours, the levels of macrophage-mediated killing
measured in isotope release assays are relatively low
and vary considerably with target cells from
different patients (Vose, 1978; Mantovani et al.,
1980; Peri et al., 1981; Haskill et al., 1982). It is
unclear whether, under these conditions, the
induction of increased isotope release by effectors
reflects a rapid elimination of effete tumour cells
already incapable of self renewal, or actual killing
of self renewing clonogenic cells. The present study
was designed to compare the interaction of
mononuclear phagocytes with ovarian carcinoma in
an isotope release assay and in a colony assay
(Courtenay et al., 1978; Hamburger & Salmon,
1977).
Materials and methods
Patients
Nine patients with advanced (stage III or IV),
histologically-proven ovarian carcinoma, admitted
to the Department of Obstetrics and Gynecology,
Ospedale San Gerardo, Monza, from October 1981
to December 1982, formed the caselist of this study.
Peripheral blood was also obtained from 10 normal
laboratory donors.
Monocytes and macrophages
Peripheral blood mononuclear cells (PBM) were
obtained by centrifugation on Ficoll-hypaque.
Monocytes were separated by sedimentation on a
one-step-gradient of Percoll as recently described
(Colotta et al., 1984). Briefly, PBM (5 x 107 in 5ml
RPMI 1640 medium with 50pgml-1 gentamicin
and 10% foetal bovine serum, (FBS), complete
medium) were layered on top of 5ml of 46% Percoll
in complete medium (285 osmol1-1) and
centrifuged at 550g for 30min. Monocytes (>90%
pure as assessed by morphology, non-specific
esterase-staining and monoclonal antibody-defined
surface markers. Colotta et al., 1984) were washed
and resuspended in complete medium. Lymphoid
cells were further depleted of contaminating
adherent cells by passage over nylon wool columns
as described (Villa et al., 1984). The nonadherent
cells contained <2% monocytes as assessed by the
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above criteria. In a limited series of experiments,
Percoll-enriched monocytes were further purified
according to the expression of M02 (the
monoclonal antibody was a kind gift of Dr R.F.
Todd, Ann Arbor, Michigan) using a FACS IV
apparatus as recently described (Colotta et al., 1984;
Villa et al., 1984). To activate monocytes, cells
(106ml-' in complete medium in 50ml Falcon
tubes) were preincubated for 20h with 1/3
lymphokine supernatant of PHA-stimulated
lymphocytes, prepared as described (Peri et al.,
1981). In part of the experiment with freshly
isolated ovarian carcinoma cells, macrophages from
ovarian cancer effusions were used as effectors after
separation by adherence on microexudate-coated
plastic as described (Mantovani et al., 1980; Peri et
al., 1981).
Cell lines
The murine SV40-transformed mKSA TU5 (TU5)
kidney line and the SW626 ovarian carcinoma line
(originated by J. Fogh, Memorial Sloan Kettering,
NY, USA) were maintained in complete medium.
For cytolysis assays, exponentially growing cultures
were exposed for 20,h to 0.5pCiml-1 [methyl-
3H]thymidine (5Cinmol-1, Radiochemical Centre,
Amersham, Bucks., UK) in 25cm2 tissue culture
flasks (Sterilin, Teddington, Middlesex, UK). Cells
were detached by 5min incubation with 2ml of
0.5% trypsin-0.02% EDTA in PBS and washed
twice with 50ml of medium before resuspension in
complete medium.
Cytolysis assay
Cytolytic activity was measured as [methyl-
3H]thymidine release in a 48h assay (Mantovani et
al., 1980). Briefly prelabelled tumour cells (104 in
0.2ml complete medium) were incubated in 6.4mm
flat-bottomed culture wells with numbers of
monocytes resulting in effector-to-target cell (E:T)
ratios ranging from 10:1 to 40:1. Isotope release
percentage was calculated as 100 x A/B, where A is
the isotope released in the supernatant and B is the
total radioactivity released by incubating target cells
in 1% SDS. Specific lysis was calculated by
subtracting the spontaneous release of tumour cells
alone, whcih did not exceed 25%.
Freshly isolated ovarian carcinoma cells
Solid ovarian tumour specimens were finely minced
mechanically and then exposed for 45-60min to
0.3% collagenase (Sigma Chemical Co., St., Louis,
MO, USA) in PBS containing 10 gml-1 DNase
(Peri et al., 1981). Malignant ascites were collected
with 10 Uml- heparin and centrifuged at 400g for
5min. Cell suspensions in PBS were centrifuged on
Ficoll-hypaque at 400g for 20min and the
mononuclear cells were washed twice with PBS. To
deplete cell suspensions of macrophages, cells
(2-5 x 106ml-') in RPMI 1640 medium were
incubated in plastic Petri dishes and then exposed
to carbonyl iron for 30min at 37°C. In an effort to
disaggregate large tumoural clumps from ascites, in
part of the experiments tumour cells were treated
for 45min with 0.3% collagenase in PBS and
washed. In order to rigorously exclude cell clumps
which are a major source of error in colony assays
(Selby et al., 1983), cell suspensions were filtered
sequentially through nylon meshes of 100, 50 and
30gm size (Spectrum Medical Industries, Terminal
Annex, L.A. USA).
Colony assay
The colony assay was essentially as described by
Hamburger & Salmon (1977). The underlayer
consisted of 1 ml of enriched McCoy's 5a medium
in 0.5% Bacto Agar (Difco Laboratories, Detroit,
MI., USA) with 10% FBS and 5% horse serum in
35mm dishes (Corning, NY, USA). Tumour cells,
after rigorous exclusion of clumps (see above), were
suspended in 0.3% agar in enriched CMLR 1066
medium with 20% horse serum. Each culture
received 2 x 105 (SW626 line) or 5 x 105 (fresh
carcinomas) tumour cells with varying numbers of
monocytes resulting in different E: T ratios.
Cultures were incubated at 37°C in humidified air
with 5% CO2. Colony counts were made 10-12
days (SW626 line) or 2 to 3 weeks (fresh
carcinomas) after plating with an inverted
microscope (100 or 200x). Groups of cells with a
diameter > 100 m were considered to be colonies.
After rigorous exclusion of cell clumps from the
initial cell suspension over this period of time we
had enough cells for testing from 30 patients and
colony formation was observed with 16
preparations; 8 of these were used for the
experiments described herein.
Statistical analysis
Results are mean +s.d. of 3 (occasionally 6)
replicates per experimental group. Significance was
assessed by Duncan's multiple range test.
Results
The SW626 ovarian carcinoma cell line selected for
these experiments was relatively resistant to human
monocyte killing. As shown in Figure 1, in a 48h
[3H]thymidine release assay, isotope release by
SW626 cells cultured with monocytes at E:T ratios
as high as 40: 1 ranged from 5 to 7%. By way ofMACROPHAGE REGULATION OF OVARIAN CANCER
30-
o 20
U,
._
.2
0.
a1 (n 10-
10:1 20:1 40:1
E:T ratio
Figure 1 Killing of the SW626 ovarian carcinoma line
by human peripheral blood monocytes (0).
Cytotoxicity was measured in a 48h [3H]thymidine
release assay. By way of comparison, results with the
TU5 line are presented (0).
comparison cytotoxicity on a 'monocyte-susceptible'
cell line (TU5) is shown. When the interaction of
monocytes with SW626 carcinoma cells was studied
in a colony assay (Figure 2), marked inhibition of
colony formation was detected. Colony formation
by TU5 cells was also dramatically decreased by
monocytes (not shown). The inhibition was
dependent on the number of monocytes added and
was already clearly detectable (33-60% inhibition in
different experiments) at E: T ratios of 0.3: 1. In the
same experiments (Figure 2) monocyte-depleted
lymphoid cells had little inhibitory activity, whereas
unseparated mononuclear cells (9-25% monocytes)
had intermediate activity. NK cells can contaminate
adherent monocyte preparations and contribute to
cytotoxicity particularly when NK-susceptible
targets are used (Chang et al., 1983; Freundlich et
al., 1984; Villa et al., 1984). Therefore we further
separated monocytes using the M02 moab and
sorting, and found inhibition of colony formation
as effective as with Percoll-enriched monocytes
(Table I). Exposure to lymphokines augments the
killing capacity of human monocytes (Peri et al.,
1981). Similarly monocyte-mediated inhibition of
SW626 colony formation was dramatically
increased by exposure of effectors to lymphokine
supernatants (Table II).
The results discussed so far were obtained using
an established ovarian cancer cell line (SW626). In
preliminary parallel experiments, we used freshly
isolated ovarian carcinoma cells as targets in the
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Figure 2 Inhibition of colony formation by SW626
ovarian carcinoma cells. (0), monocytes; (0),
monocyte-depleted lymphoid cells; (E1), unseparated
mononuclear cells (upper panel) experiment 1; (lower
panel) experiment 2.
colony assay (Table III). In some of these tests,
peritoneal ascites macrophages were used as
effectors.
Ovarian carcinoma cells from different patients
were heterogeneous in their susceptibility to colony
inhibition by monocytes, some tumour cell
preparations (nos. 1,2,4, 5 and 9) being resistant to
cytotoxicity. Carcinoma cells from one patient (no.
4) showed enhanced colony formation in the
c
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Table I Inhibition of SW626 colony formation by monocytes separated by M02
monoclonal antibody and sorting
Number ofcoloniesl Inhibition
Effector cells E: T ratio dish (±s.d.) (%)
2,148+200
Percoll-enriched 1:1 801 + 1loa 62.7
monocytes 3:1 609+ 54a 71.6
FACS-separated 1:1 737+ 11la 65.7
MO2+ monocytes 3:1 673+254a 68.7
Percoll-enriched monocytes were further purified according to the expression of
M02 using a FACS IV apparatus. Recovery of M02- cells did not permit testing
this population; aSignificantly lower (P<0.01) than SW626 cells alone.
Table II Augmentation by lymphokines of monocyte-
mediated SW626 colony inhibition
Number ofcolonies/dish at E: T
Monocytes
incubated with 0.3:1 1:1 3:1
Medium 625+204 384+ 0 144+68
Lymphokines 384+ loa 240+69a 96+ oa
Monocytes were preincubated for 20h with 1/3 diluted
lymphokine supernatant. The number of colonies in dishes
with SW626 carcinoma alone was 1,540+408. ap<0.05.
presence of mononuclear phagocytes. In case.no. 5,
mononuclear phagocytes tended to increase the
number of colonies at low E: T ratios, but this
difference was not significant.
Discussion
In assessing the cytotoxic potential of effector
populations on relatively resistant target cells, one
is frequently confronted with low levels of isotope
release. Typically, this occurs in studies with
monocytes and certain lines or fresh tumours (e.g.
Vose & Moore, 1980; Mantovani et al., 1980; Peri
et al., 1981; Haskill et al., 1982; Moore et al, 1982;
Miner & Nicolson, 1983; Urban & Schreiber, 1983)
or with NK cells when fresh non-cultured targets
are used (e.g. Introna & Mantovani, 1983). The
biological significance of these low levels of killing
is uncertain, one possibility being that they reflect
acceleration of death of damaged, effete tumour
cells. In the present study we addressed the
question of the effect of monocytes on colony
formation by ovarian carcinoma cells, which
frequently show little or no isotope release when
confronted with monocytic or NK effectors
(Mantovani et al., 1980; Haskill et al., 1982). While
normal human monocytes at E: T ratios as high as
40: 1 had little if any, killing capacity in a 48h [3H]-
thymidine release assay against SW626 ovarian
carcinoma cells, inhibition of colony formation was
detected at ratios as low as 0.2: 1. The monocytic
Table III Modulation by mononuclear phagocytes of colony formation by freshly isolated
ovarian carcinoma cells
Colonies/dish at E: T ratio of
Patient
no. Tumour 0.2:1 1:1 5:1
I Ascites 1,052+150 NTC 1,052+212 751+ 0
2 Ascites 2,743+537 NT 2,742+ 58 NT
3 Ascites 654+ 30 NT 295+ oa NT
4 Solid 886+ 178 NT NT 1,688±+118ab
5 Solid 760+ 0 1,012+238 591+120 591+120
6 Solid 253+ 40 183+ 20 98+ 20a NT
7 Ascites 570+ 90 359+ 90 169+ oa NT
8 Solid 485+ 30 NT NT 148+ 30a
9 Ascites 481+ 68 408+ 35 408+ 35 NT
Normal blood monocytes were used as effectors except for case nos. 1, 2, 5 and 6 in which
tumour-associated macrophages were employed; aSignificantly different (P<0.05) from
ovarian carcinoma cells alone; bThe E:T ratio was 10: 1; CNT, not tested.MACROPHAGE REGULATION OF OVARIAN CANCER 51
nature of effector cells was established by
separating monocytes according to the expression
of M02 (Todd et al., 1981) and by the virtually
complete lack of activity of monocyte-depleted
lymphoid cells. As expected, lymphokine
supernatants markedly augmented the inhibitory
capacity of monocytes on SW626 colony formation.
Thus, isotope release assays may indeed
underestimate the potential of effectors to interfere
with clonogenic cells capable of self-renewal, that
may be enumerated in a colony assay.
In a limited series of assays, we extended the
evaluation of the monocyte-ovarian carcinoma
interaction in the colony assay to freshly isolated
ovarian tumours. The need for rigorous elimination
of cell aggregates before the assay (a frequent
occurrence in ovarian cancer) and the limited
success rate in getting colonies (53% of evaluable
cases) left us with only 9 evaluable, though limited,
experiments (Table III). In spite of these
limitations, the results obtained raise some
interesting points. Freshly isolated ovarian
carcinoma cells from different patients were
remarkably heterogeneous in their susceptibility to
colony inhibition by monocytes. This finding
confirms previous data in a [5Cr]-release assay
(Haskill et al., 1982) or in a [3H]-thymidine release
assay (Mantovani et al., 1980; Peri et al., 1981).
Moreover, in one subject monocytes augmented
colony formation, an observation in agreement with
previous data on the promoting effect of
mononuclear phagocytes in ovarian cancer in
isotopic or colony assays (Mantovani et al., 1979,
1980; Buick et al., 1980). These observations
emphasize the potential of mononuclear phagocytes
for dual (up or down) regulation of tumour growth.
Which of these regulatory influences predominates
in tumour-infiltrating macrophages in different
stages of tumour progression has been elucidated
only to a very limited extent (see for discussion
Evans, 1979; Mantovani, 1983). Colony assays are
cumbersome and time-consuming, particularly when
fresh.tumours are used. However, they may provide
an important methodological approach, particularly
when effector cells mediate low levels of killing in
conventional isotope-release assays or when growth
promotion is to be evaluated.
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